Exclusive

Publication

Byline

Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, June 20 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combin... Read More


Singapore Clinical Trial: A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combined with Chemotherapy Versus Investigator’s Choice of TKI Combined with Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Singapore, June 20 -- The Health Sciences Authority received information related to the study titled 'A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Olverembatinib Combin... Read More


Singapore Clinical Trial: 'Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the post-operative survival of glaucoma drainage devices'

Singapore, June 20 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the po... Read More


Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, June 20 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... Read More


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, June 20 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, June 20 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... Read More


NEET-UG exam row: Nagpur-based aspirant gets Abu Dhabi as re-test centre; NTA admits mistake

New Delhi, June 20 -- A day ahead of the National Eligibility cum Entrance Test (NEET-UG) re-examination, a glaring glitch on the part of the National Testing Agency (NTA) has now surfaced. A Nagpur-b... Read More


Kenneth Nwa Okonkwo: The actor who brings his character to life, By Osmund Agbo

Nigeria, June 20 -- In Greek mythology, there is the fascinating story of Pygmalion, a gifted sculptor from the island of Cyprus. Disillusioned by the women around him, Pygmalion resolved never to mar... Read More


Admissions Open 2026-27 at ASCT's Lalit Seth Institute for Aviation & Logistics Careers

New Delhi, June 20 -- Mr. Lalit Kumar Seth Founder & Chairman, ASCT's Lalit Seth Institute of Aviation & Logistics Management Mumbai (Maharashtra) [India], June 20: ASCT's Lalit... Read More


House of Electrons Launches in India with Exclusive Limited-Edition Electronics and Gaming Accessories

New Delhi, June 20 -- Bengaluru (Karnataka) [India], June 19 : House of Electrons, a new destination for technology enthusiasts, gamers and gadget lovers, proudly announces the official launch ... Read More